There are studies reporting lncRNA FOXD2-AS1 in papillary thyroid carcinoma, colorectal cancer, and bladder cancer are highly expressed and have a more significant correlation with poor prognosis, all of which can be used as molecular markers [17, 27, 28]. The gene discussed is FOXD2; the disease is differentiated thyroid carcinoma.